Abstract | OBJECTIVES: METHODS: In the reversal protocol, adult mice were first given d-amphetamine (AMPH) 2 mg/kg, intraperitoneally (i.p.) or saline for 14 days. Between days 8 and 14, the animals received ALA 50 or 100 mg/kg orally, lithium (Li) 47.5 mg/kg i.p., or saline. In the prevention paradigm, mice were pretreated with ALA, Li, or saline prior to AMPH. Locomotor activity was assessed in the open-field task. Superoxide dismutase (SOD) activity, reduced glutathione (GSH), and thiobarbituric acid-reactive substance ( TBARS) levels were evaluated in the prefrontal cortex (PFC), hippocampus (HC), and striatum (ST). Brain-derived neurotrophic factor ( BDNF) levels were measured in the HC. RESULTS: ALA and Li prevented and reversed the AMPH-induced increase in locomotor activity. PREVENTION MODEL: ALA and Li co-administration with AMPH prevented the decrease in SOD activity induced by AMPH in the HC and ST, respectively; ALA and Li prevented GSH alteration in the HC and TBARS formation in all brain areas studied. REVERSAL MODEL: ALA reversed the decrease in SOD activity in the ST. TBARS formation was reversed by ALA and Li in all brain areas. Furthermore, ALA reversed AMPH-induced decreases in BDNF and GSH in the HC. CONCLUSIONS: Our findings showed that ALA, similarly to Li, is effective in reversing and preventing AMPH-induced behavioral and neurochemical alterations, providing a rationale for the design of clinical trials investigating ALA's possible antimanic effect.
|
Authors | Danielle S Macêdo, Camila D Medeiros, Rafaela C Cordeiro, Francisca Cléa Sousa, Júnia V Santos, Thomás A Morais, Thomas N Hyphantis, Roger S McIntyre, João Quevedo, André F Carvalho |
Journal | Bipolar disorders
(Bipolar Disord)
Vol. 14
Issue 7
Pg. 707-18
(Nov 2012)
ISSN: 1399-5618 [Electronic] Denmark |
PMID | 22897629
(Publication Type: Journal Article)
|
Copyright | © 2012 John Wiley and Sons A/S. |
Chemical References |
- Antimanic Agents
- Brain-Derived Neurotrophic Factor
- Central Nervous System Stimulants
- Thiobarbituric Acid Reactive Substances
- Malondialdehyde
- Thioctic Acid
- Superoxide Dismutase
- Lithium Chloride
- Glutathione
- Dextroamphetamine
|
Topics |
- Animals
- Antimanic Agents
(therapeutic use)
- Bipolar Disorder
(blood, chemically induced, drug therapy)
- Brain
(drug effects, metabolism, pathology)
- Brain-Derived Neurotrophic Factor
(metabolism)
- Central Nervous System Stimulants
(toxicity)
- Dextroamphetamine
(toxicity)
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Glutathione
(metabolism)
- Lipid Peroxidation
(drug effects)
- Lithium Chloride
(blood, therapeutic use)
- Male
- Malondialdehyde
(metabolism)
- Mice
- Motor Activity
(drug effects)
- Superoxide Dismutase
(metabolism)
- Thiobarbituric Acid Reactive Substances
(metabolism)
- Thioctic Acid
(therapeutic use)
|